Bacteriological characterization of vancomycin-resistant enterococci in a pediatric hospital in Turkey

Annals of Microbiology

Volumn 54, Issue 4, 2004, Pages 543-551

  Kilic, A ^a   Demiray, T ^b   Saracli, M A ^a   Bahar, G ^b   Aydogan, H ^a   Baysallar, M ^a   Doganci, L ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Neurosurgery Clinic   (Turkey)

Author keywords

Nosocomial outbreak; vanA; VRE

Indexed keywords

ENTEROCOCCUS; ENTEROCOCCUS FAECIUM;

EID: 16844364757     PISSN: 15904261     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Allen G.P., Cha R., Rybak M.J. (2002). In vitro activities of quinupristin-dalfopristin and cefepime, alone and in combination with various antimicrobials, against multidrug-resistant staphylococci and enterococci in an in vitro pharmacodynamic model. Antimicrob. Agents Ch., 46: 2606-2612.
2. Bell J.M., Paton J.C., Turnidge J. (1998). Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J. Clin. Microbiol., 36: 2187-2190.
3. Bingen E.H., Denamur E., Lambert-Zechovsky N.Y., Elion J. (1991). Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J. Clin. Microbiol., 29: 1888-1192.
4. Boyce J.M., Opal S.M., Chow J.W., Zervos M.J., Potter-Bynoe G., Sherman C.B., Romulo R.L., Fortna S., Medeiros A.A. (1994). Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J. Clin. Microbiol., 32: 1148-1153.
5. Chadwick P.R., Oppenheim B.A., Fox A., Woodford N., Morgenstern G.R., Scarffe J.H. (1996). Epidemiology of an outbreak due to glycopeptide-resistant Enterococcus faecium on a leukaemia unit. J. Hosp. Infect., 34: 171-182.
6. Colak D., Naas T., Gunseren F., Fortineau N., Ogunc D., Gultekin M., Nordmann P. (2002). First outbreak of vancomycin-resistant enterococci in a tertiary hospital in Turkey. J. Antimicrob. Chemother., 50: 397-401.
7. Descheemaeker P., Ieven M., Chapelle S., Lammens C., Hauchecorne M., Wijdooghe M., Vandamme P., Goossens H. (2000). Prevalence and molecular epidemiology of glycopeptide-resistant enterococci in Belgian renal dialysis units. J. Infect. Dis., 181: 235-241.
8. Dice L.R. (1945). Measures of the amount of ecological association between species. Ecology, 26: 297-302.
9. Dutka-Malen S., Evers S., Courvalin P. (1995). Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR. J. Clin. Microbiol., 33: 24-27.
10. Edmond M.B., Ober J.F., Weinbaum D.L., Pfaller M.A., Hwang T., Sanford M.D., Wenzel R.P. (1995). Vancomycin-resistant Enterococcus faecium bacteremia: risk factors for infection. Clin. Infect. Dis., 20: 1126-1133.
11. Eisner H.A., Sobottka I., Feucht H.H., Harps E., Haun C., Mack D., Ganschow R., Laufs R., Kaulfers P.M. (2000). Nosocomial outbreak of vancomycin-resistant Enterococcus faecium at a German university pediatric hospital. Int. J. Hyg. Envir. Heal., 203: 147-152.
12. Henning K.J., Delencastre H., Eagan J., Boone N., Brown A., Chung M., Wollner N., Armstrong D. (1996). Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infection. Pediatr. Infect. Dis. J., 15: 848-854.
13. Jayaratne P., Rutherford C. (1999). Detection of clinically relevant genotypes of vancomycin-resistant enterococci in nosocomial surveillance specimens by PCR. J. Clin. Microbiol., 37: 2090-2092.
14. Luh K.T., Hsueh P.R., Teng L.J., Pan H.J., Chen Y.C., Lu J.J., Wu J.J., Ho S.W. (2000). Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob. Agents Ch., 44: 3374-3380.
15. Morris J.G. Jr, Shay D.K., Hebden J.N., McCarter R.J. Jr, Perdue B.E., Jarvis W., Johnson J.A., Dowling T.C., Polish L.B., Schwalbe R.S. (1995). Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann. Intern. Med., 123: 250-259.
16. Morrison D., Woodford N., Barrett S.P., Sisson P., Cookson B.D. (1999). DNA banding pattern polymorphism in vancomycin-resistant Enterococcus faecium and criteria for defining strains. J. Clin. Microbiol., 37: 1084-1091.
17. National Committee for Clinical Laboratory Standards (2000). Performance standards for antimicrobial susceptibility testing: eighth informational supplement. NCCLS document M100-S8. NCCLS, Villanova, PA.
18. Nourse C., Murphy H., Byrne C., O'Meara A., Breatnach F., Kaufmann M., Clarke A., Butler, K. (1998). Control of a nosocomial outbreak of vancomycin resistant Enterococcus faecium in a paediatric oncology unit: risk factors for colonisation. Eur. J. Pediatr., 157: 20-27.
19. Padiglione A.A., Grabsch E.A., Olden D., Hellard M., Sinclair M.I., Fairley C.K., Grayson M.L. (2000). Fecal colonization with vancomycin-resistant enterococci in Australia. Emerg. Infect. Dis., 6: 534-536.
20. Papaparaskevas J., Tassios P.T., Kalapothaki V., Avlami A., Legakis N.J., Vatopoulos A.C. (2002). Epidemiology of multiresistant Enterococcus avium isolates in a Greek tertiary care hospital. Int. J. Antimicrob. Agents, 20: 432-437.
21. Perez-Hernandez X., Mendez-Alvarez S., Claverie-Martin F. (2002). A PCR assay for rapid detection of vancomycin-resistant enterococci. Diagn. Microbiol. Infect. Dis., 42: 273-277.
22. Plessis P., Lamy T., Donnio P.Y., Autuly F., Grulois I., Le Prise P.Y., Avril J.L. (1995). Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur. J. Clin. Microbiol. Infect. Dis., 14: 959-963.
23. Radu S., Toosa H., Rahim R.A., Reezal A., Ahmad M., Hamid A.N., Rusul G., Nishibuchi M. (2001). Occurrence of the vanA and vanC2/C3 genes in Enterococcus species isolated from poultry sources in Malaysia. Diagn. Microbiol. Infect. Dis., 39: 145-153.
24. Roger M., Faucher M.C., Forest P., St-Antoine P., Coutlee F. (1999). Evaluation of a vanA-specific PCR assay for detection of vancomycin-resistant Enterococcus faecium during a hospital outbreak. J. Clin. Microbiol., 37: 3348-3349.
25. Rubin L.G., Tucci V., Cercenado E., Eliopoulos G., Isenberg H.D. (1992). Vancomycin-resistant Enterococcus faecium in hospitalized children. Infect. Control. Hosp. Epidemiol., 13: 700-705.
26. Schouten M.A., Hoogkamp-Korstanje J.A., Meis J.F., Voss A. (2000). European VRE Study Group. Prevalence of vancomycin-resistant enterococci in Europe. Eur. J. Clin. Microbiol. Infect. Dis., 19: 816-822.
27. Sneath P.H.A., Sokal R.R. (1973). The estimation of taxonomic resemblance, In: Numerical taxonomy. W.H. Freeman & Co., San Francisco, Calif., pp. 114-187.
28. Uttley A.H., Collins C.H., Naidoo J., George R.C. (1988). Vancomycin-resistant enterococci. Lancet, 1: 57-58.